- Home
- ROIV vs PLNT Comparison
ROIV vs PLNT Comparison
Compare ROIV & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | PLNT |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 9.1B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ROIV | PLNT |
|---|---|---|
| Price | $21.70 | $108.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $24.31 | ★ $118.77 |
| AVG Volume (30 Days) | ★ 8.2M | 1.2M |
| Earning Date | 02-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.23 |
| EPS | N/A | ★ 2.44 |
| Revenue | $20,329,000.00 | ★ $1,202,700,000.00 |
| Revenue This Year | N/A | $21.43 |
| Revenue Next Year | $741.42 | $11.05 |
| P/E Ratio | ★ N/A | $44.44 |
| Revenue Growth | N/A | ★ 14.63 |
| 52 Week Low | $8.73 | $87.72 |
| 52 Week High | $23.47 | $114.47 |
Technical Indicators
Market Signals| Indicator | ROIV | PLNT |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 49.66 |
| Support Level | $21.36 | $108.07 |
| Resistance Level | $22.72 | $112.54 |
| Average True Range (ATR) | 0.80 | 2.14 |
| MACD | -0.13 | -0.50 |
| Stochastic Oscillator | 45.71 | 9.01 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.